) B.E. 2551 (2008), and Section 35, Section 36, Section 67, Section 69 and Section 80 of the Securities and Exchange Act B.E. 2535 (1992), the Capital Market Supervisory Board hereby issues the following
issues this Notification of Guidelines, as follows: Clause 1 The Guidelines deal with the following matters: (1) establishment of policies, measures and operating systems relating to the governance of
issues this Notification of Guidelines, as follows: Clause 1 The Guidelines deal with the following matters: (1) establishment of policies, measures and operating systems relating to the governance of
, Section 69 and Section 80 of the Securities and Exchange Act B.E. 2535 (1992), the Capital Market Supervisory Board hereby issues the following regulations: Clause 1 This Notification shall come into force
Capital Market Supervisory Board hereby issues the following regulations: Clause 1 This Notification shall come into force as from 1 April 2019. Clause 2 The following notifications shall be repealed: (1
) and (4), Section 42(10) and Section 43(3) of the Securities and Exchange Act B.E. 2535 (1992), the Capital Market Supervisory Board hereby issues the following regulations: Clause 1 This Notification
February 2018. The Company would like to inform that the Company has proposed the solutions with the significant issues from the study of such solutions as follows: (1) Analysis on cost of the treatment of
Company according to the proportion of shareholding subscribed and paid up capital of the Company not more than 268,953,447 units Agenda 7 Other issues (if any) This is because Agenda 2 to Agenda 6 is
Company according to the proportion of shareholding subscribed and paid up capital of the Company not more than 268,953,447 units Agenda 7 Other issues (if any) This is because Agenda 3 to Agenda 6 is
international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug